![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, January 25, 2021 1:44:02 PM
My point is that we can guess, but we'll never know for certain. When TLD is released, we may learn of a Journal publication, method of expedited approval, etc. and we can guess that it's what held up TLD, but we really won't know it's a fact.
Perhaps some day L.P., Dr. Liau, and others will decide to write a book about what's happened in the last 15 or so years, but I seriously doubt it. I've often thought a Biotech version of the Sting should have been made showing how in the development of Erbitux, BMY was stung into a multi-billion dollar partnership that ultimately resulted in Martha Steward and Sam Waksal the CEO of IMCL being jailed. After that case FDA rules were changed, but prior to that time a company could lie about what the FDA was saying, and the FDA's hands were tied about calling out the lie. The Sting was based on the FDA routinely telling IMCL that they had qualms with the clinical trials, but IMCL telling BMY that all was great with the FDA.
I believe we've had hints from the company about delays caused by regulators, but because of the IMCL case, if the company were to say anything that the FDA disagreed with, the FDA would be free to speak out about it. Companies rarely speak about anything they're doing with the FDA or other regulators, so while we can guess that delays have been caused by the regulators, almost no company will ever say so, and the regulators will only speak if a company has lied about what they've done, or said.
Every day we're one day closer to when we'll learn about the trial, that's about as positive as we can be. Will it come in the next 5 days, or 100 days, no one will actually say. When it happens, have no doubt, we'll know it.
Gary
Recent NWBO News
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM
Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM